Publication

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

Stein, R., Bogaert, G. A., Dogan, H. S., Hoen, L., Kocvara, R., Nijman, R. J. M., Quadackers, J., Rawashdeh, Y. F., Silay, M. S., Tekgul, S. & Radmayr, C., 3-Dec-2019, In : Neurourology and urodynamics. 39, 2, p. 498-506 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Copy link to clipboard

Documents

  • EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

    Final publisher's version, 993 KB, PDF document

    Request copy

DOI

  • Raimund Stein
  • Guy A. Bogaert
  • Hasan S. Dogan
  • Lisette Hoen
  • Radim Kocvara
  • Rien J. M. Nijman
  • Josine Quadackers
  • Yazan F. Rawashdeh
  • Mesrur S. Silay
  • Serdar Tekgul
  • Christian Radmayr

Background Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimes-even in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. Material & Methods After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update. Results In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option. Conclusion In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early.

Original languageEnglish
Pages (from-to)498-506
Number of pages9
JournalNeurourology and urodynamics
Volume39
Issue number2
Publication statusE-pub ahead of print - 3-Dec-2019

    Keywords

  • bladder augmentation, bladder neck reconstruction, EAU guideline, Mitrofanoff stoma, neurogenic bladder, sling procedure, urinary diversion, ARTIFICIAL URINARY SPHINCTER, TERM-FOLLOW-UP, BOTULINUM-TOXIN-A, AUGMENTATION CYSTOPLASTY, SPINA-BIFIDA, VESICOURETERAL REFLUX, NEUROPATHIC BLADDER, ILEAL CONDUIT, INTRAVESICAL ELECTROTHERAPY, ENDOSCOPIC INJECTION

ID: 109495802